arrow
C

Caroline Morbach

University Hospital Wurzburg
H指数:24
被引数:2,657

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Continuous Vutrisiran Reduces Cardiovascular Events and Hospitalizations in Patients With Transthyretin Amyloidosis With Cardiomyopathy in the HELIOS-B One-Year Open Label Extension

连续注射Vutrisiran可降低伴心肌病的甲状腺素转运蛋白淀粉样变性患者的心血管事件和住院率:HELIO-B研究一年开放标签扩展研究

2026-10-110
OA
Disease modifying treatment of hereditary transthyretin amyloidosis with polyneuropathy in Germany – expert consensus of the German society of amyloid diseases (DGAK) and the German neurological society (DGN)

德国遗传性甲状腺素转运蛋白淀粉样变性伴多发性神经病变的疾病修饰治疗——德国淀粉样变性学会(DGAK)和德国神经病学学会(DGN)的专家共识

2026-08-110
OAAI
Transthoracic echocardiography Guidelines of the German Society for Ultrasound in Medicine, German Cardiac Society, German Society of Anesthesiology and Intensive Care Medicine, German Society of Internal Medicine, Professional Association of German Internists, and the German Association of Cardiologists in Private Practice (Association of Scientific Medical Societies in Germany, S2k LL85-004, 9/1/2025)

经胸超声心动图指南:德国医学超声学会、德国心脏学会、德国麻醉学与重症监护医学会、德国内科学会、德国内科医师专业协会以及德国私人执业心脏病学家协会(德国科学医学学会协会,S2k LL85-004,9/1/2025)

2026-02-010
OA
Cardioimmunologic response patterns after an acute heart failure event: Design and first results of AHF-ImmunoCS

急性心力衰竭事件后的心免疫学反应模式:AHF-ImmunoCS的设计与初步结果

2025-10-300
OAAI
Effects of vutrisiran on cardiac structure and function in patients with transthyretin amyloidosis with cardiomyopathy: secondary outcomes of the HELIOS-B trial

vutrisiran对患有心肌病的转甲状腺素蛋白淀粉样变性患者的心脏结构和功能的影响: helios-b试验的次要结果

2025-08-060
OAAI
Impact of Vutrisiran on Cardiac Biomarkers in Patients With Transthyretin Amyloidosis With Cardiomyopathy From HELIOS-B

Vutrisiran对伴有心肌病的甲状腺素转运蛋白淀粉样变性患者心脏生物标志物的影响:来自HELIOS-B的研究

2025-08-040
OA
Factors associated with reduction in quality of life after SARS-CoV-2 infection

SARS-CoV-2感染后生活质量下降的相关因素

2025-02-260
OAAI
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
2025-01-0213
PRE
Real-world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational study

心脏转甲状腺素蛋白淀粉样变性的真实世界特征和治疗: 一项多中心观察性研究

2024-11-060
OA